Topical therapy for oropharyngeal symptoms of myasthenia gravis
- PMID: 3963762
- DOI: 10.1002/ana.410190214
Topical therapy for oropharyngeal symptoms of myasthenia gravis
Abstract
Inhibitors of acetylcholinesterase are commonly used in the treatment of myasthenia gravis. We studied a patient with mainly bulbar myasthenia gravis who did not tolerate oral pyridostigmine despite a clear clinical response. Treatment with nebulized pyridostigmine reduced her symptoms without systemic side effects. This route of therapy may benefit other patients.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical